Metraipolis › archive › dc_164339149d52

YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41304997

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304997
DOI
10.3390/ph18111752
License (as archived)
solo-consultazione
Archived
2026-11-08T11:33:17.130Z
SHA-256 of the archived text
2df967c543a4cd2759c49dddcb9e79dec74660a6d448fe88f0b188f7f93f3b8b
Stable URL of this page
https://metraipolis.com/documento/dc_164339149d52

How to cite

YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41304997 — Europe PMC (en), https://europepmc.org/article/MED/41304997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_164339149d52 (Metraipolis archive dc_164339149d52, sha256 2df967c543a4cd2759c49dddcb9e79dec74660a6d448fe88f0b188f7f93f3b8b)
BibTeX
@misc{dc164339149d52,
  title = {YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer — Europe PMC PMID:41304997},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304997},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_164339149d52; sha256 2df967c543a4cd2759c49dddcb9e79dec74660a6d448fe88f0b188f7f93f3b8b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304997. Agents can read the archived copy with the MCP tool read_document.